Found: 9
Select item for more details and to access through your institution.
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System.
- Published in:
- International Journal of Neuropsychopharmacology, 2022, v. 25, n. 9, p. 727, doi. 10.1093/ijnp/pyac031
- By:
- Publication type:
- Article
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 8, p. 977, doi. 10.3390/ph15080977
- By:
- Publication type:
- Article
The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco‐toxicological data to assess and potentially mitigate their diffusion to water supplies.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2020, doi. 10.1111/bcp.15761
- By:
- Publication type:
- Article
Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4610, doi. 10.3390/cancers14194610
- By:
- Publication type:
- Article
Exploring the underlying mechanisms of drug‐induced impulse control disorders: a pharmacovigilance‐pharmacodynamic study.
- Published in:
- Psychiatry & Clinical Neurosciences, 2023, v. 77, n. 3, p. 160, doi. 10.1111/pcn.13511
- By:
- Publication type:
- Article
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS.
- Published in:
- Drug Safety, 2024, v. 47, n. 3, p. 271, doi. 10.1007/s40264-023-01391-4
- By:
- Publication type:
- Article
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach.
- Published in:
- Drug Safety, 2023, v. 46, n. 10, p. 921, doi. 10.1007/s40264-023-01345-w
- By:
- Publication type:
- Article
Authors' Reply to Cappello et al. Comment on: "Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System".
- Published in:
- Drug Safety, 2023, v. 46, n. 9, p. 919, doi. 10.1007/s40264-023-01331-2
- By:
- Publication type:
- Article
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System.
- Published in:
- Drug Safety, 2023, v. 46, n. 3, p. 283, doi. 10.1007/s40264-022-01269-x
- By:
- Publication type:
- Article